Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)
Xiamen University
Xiamen University
Ruhr University of Bochum
Peking Union Medical College Hospital
Azienda USL Toscana Nord Ovest
Xiamen University
M.D. Anderson Cancer Center
Universiteit Antwerpen
Xiamen University
Maastricht University Medical Center
Erasmus Medical Center
New York Presbyterian Hospital
Medical University of Vienna
M.D. Anderson Cancer Center
Oswaldo Cruz Foundation
Oswaldo Cruz Foundation
Columbia University
Chiang Mai University
University Hospital, Tours
Ontario Clinical Oncology Group (OCOG)
University of California, Irvine